NDC 61314-654 – Pyzchiva

Ustekinumab 130 mg/26mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC61314-654

Product details

Brand name
Pyzchiva
Generic name
Ustekinumab-ttwe
Labeler
SANDOZ INC
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
BLA · BLA761425
Marketed since
February 22, 2025
Listing expires
December 31, 2027
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Pyzchiva →

Package NDC codes (1)

Package NDCDescriptionSince
61314-654-941 VIAL, SINGLE-USE in 1 CARTON (61314-654-94) / 26 mL in 1 VIAL, SINGLE-USEFeb 22, 2025

Other Pyzchiva products